IMR Press / FBL / Volume 13 / Issue 8 / DOI: 10.2741/2890

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with Frontiers in Bioscience.

FGF signaling: its role in bone development and human skeleton diseases
Show Less
1 State Key Laboratory of Trauma, Burns and Combined Injury, Trauma Center, Institute of Surgery Research, Daping Hospital, Third Military Medical University, Chongqing 400042, China

*Author to whom correspondence should be addressed.

Academic Editor: Chuan-Ju Liu

Front. Biosci. (Landmark Ed) 2008, 13(8), 2842–2865;
Published: 1 January 2008
(This article belongs to the Special Issue ADAMTS-18: A metalloproteinase with multiple functions)

Fibroblast growth factors (FGFs)/Fibroblast growth factor receptors (FGFRs) signaling has recently been found to play very important roles in bone development and diseases. Missense mutations in several FGFs and FGFRs were found in human to cause a variety of congenital bone diseases including chondrodysplasia syndromes, craniosynostosis syndromes, and syndromes with dysregulated phosphate metabolism, etc. In addition to its role in bone development and genetic diseases, FGF signaling is also involved in the maintenance of adult bone homeostasis and fracture healing, etc. Understanding the underlying molecular mechanisms for the role of FGFs/FGFRs in the regulation of bone development and diseases will ultimately lead to better prevention and treatment of FGF signaling-related bone diseases. In this review, we are going to give a summary of the role of FGFs/FGFRs in skeleton development and diseases, and pay more attention to those recent progresses.

Back to top